Alessandro Grattoni
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 45
- Nanoparticle-Based Drug Delivery 45
-
- Advanced Drug Delivery Systems 27
- Co-authors
- Mauro Ferrari (38 shared papers)Corrine Ying Xuan Chua (50 shared papers)Nicola Di Trani (38 shared papers)Jason H. Sakamoto (3 shared papers)Fernanda Paola Pons-Faudoa (11 shared papers)Usha R. Thekkedath (7 shared papers)Danilo Demarchi (20 shared papers)Simone Capuani (15 shared papers)
- Journals
- Journal of Controlled Release (8 papers)Advanced Healthcare Materials (7 papers)Lab on a Chip (6 papers)Biomedical Microdevices (6 papers)Advanced Therapeutics (6 papers)
- Partner nations
- United StatesItalyChina
In The Last Decade
Alessandro Grattoni
129 papers receiving 3.8k citations
Alessandro Grattoni's Hit Papers
Peers
Comparison fields: 5 of 139
- Pharmaceutical Science 739
- Biomaterials 901
- Drug Discovery 13
- Biomedical Engineering 1.1k
- Molecular Medicine 173
Countries citing papers authored by Alessandro Grattoni
This map shows the geographic impact of Alessandro Grattoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Grattoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Grattoni more than expected).
Fields of papers citing papers by Alessandro Grattoni
This network shows the impact of papers produced by Alessandro Grattoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Grattoni. The network helps show where Alessandro Grattoni may publish in the future.
Co-authors
The 25 scholars most cited alongside Alessandro Grattoni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 134 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 205 | |
| 2 | 2010 | 175 | |
| 3 | 2019 | 174 | |
| 4 | 2018 | 162 | |
| 5 | 2022 | 134 | |
| 6 | 2020 | 101 | |
| 7 | 2021 | 86 | |
| 8 | 2010 | 77 | |
| 9 | 2017 | 77 | |
| 10 | 2013 | 74 | |
| 11 | 2018 | 74 | |
| 12 | 2018 | 71 | |
| 13 | 2013 | 70 | |
| 14 | 2020 | 64 | |
| 15 | 2020 | 56 | |
| 16 | 2021 | 56 | |
| 17 | 2011 | 53 | |
| 18 | 2018 | 53 | |
| 19 | 2019 | 53 | |
| 20 | 2019 | 53 |
About Alessandro Grattoni
Alessandro Grattoni is a scholar working on Biomaterials, Pharmaceutical Science, Biomedical Engineering, Surgery and Infectious Diseases, having authored 134 papers that have together received 3.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (45 papers), Advanced Drug Delivery Systems (27 papers), Nanopore and Nanochannel Transport Studies (21 papers), Microfluidic and Capillary Electrophoresis Applications (20 papers), Pancreatic function and diabetes (15 papers), Tissue Engineering and Regenerative Medicine (15 papers), Cancer Immunotherapy and Biomarkers (9 papers) and HIV/AIDS Research and Interventions (9 papers). The work is most often cited by research in Pharmaceutical Science (739 citations), Biomaterials (901 citations), Drug Discovery (13 citations), Biomedical Engineering (1.1k citations) and Molecular Medicine (173 citations). Alessandro Grattoni has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Mauro Ferrari, Corrine Ying Xuan Chua, Nicola Di Trani, Jason H. Sakamoto, Fernanda Paola Pons-Faudoa, Usha R. Thekkedath, Danilo Demarchi, Simone Capuani, Marco Farina and Giacomo Bruno. Their work appears in journals such as Journal of Controlled Release, Advanced Healthcare Materials, Lab on a Chip, Biomedical Microdevices and Advanced Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.